ESCMID eLibrary

Search results

Icon explanation

close

Abstract

ePoster

Handout

Image

Journal Article

Presentation

Video

Webcast

1. O250

   Outcome of patients with bacteraemia due to Enterobacteriaceae treated with fluoroquinolones accruing to MIC (REIPI bacteraemia-MIC study)

   Adoracion Valiente Mendez, Seville, Spain

   Torres, E.(1)*; Peñas, C.(1); Delgado-Valverde, M.(1); Planes, A.M.(2); Peña Miralles, C.(3); Borrell, N.(4); Corzo Delgado, J.(5); Valiente Mendez, A.(1); Pascual, A.(1); Rodriguez-Baño, J.(1);

   13 May 2014

   Session: New old antibiotics: safety and efficacy

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   Oral presentation

   New Antibacterial Agents & Stewardship

2. O251

   Cross-sectional study: an international survey on controversial antibiotic options in infective endocarditis

   Guillaume Béraud, Poitiers, France

   Béraud, G.(1)*; Pulcini, C.(2); Paño-Pardo, J.R.(3); Hoen, B.(4); Beovic, B.(5); Nathwani, D.(6);

   13 May 2014

   Session: Improving treatment of severe infections

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   Oral presentation

   New Antibacterial Agents & Stewardship

3. O252

   Antistaphylococcal beta-lactams vs vancomycin in the treatment of infective endocarditis due to methicillin-susceptible coagulase-negative staphylococci - a prospective cohort study from the international collaboration on endocarditis

   Manuela Carugati, Milan, Italy

   Carugati, M.(1)*; Arnold, C.(2); Miro', J.(3); Kanafani, Z.(4); Bayer, A.(5); Chu, V.(6);

   13 May 2014

   Session: Improving treatment of severe infections

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   Oral presentation

   Bacterial Infection & Disease

4. O253

   Effect of days of therapy on detection of pathogens from sterile clinical specimens submitted for culture following initiation of antibiotic treatment

   John Farrell, Peoria (IL), United States

   Farrell, J.J.(1)*; Wang, H.(1); Sampath, R.(2); Bonomo, R.A.(3);

   13 May 2014

   Session: Improving treatment of severe infections

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   Oral presentation

   New Antibacterial Agents & Stewardship

5. O254

   In vivo development of fluoroquinolone and macrolide resistance in Streptococcus pneumoniae

   Jose Maria Marimon Ortiz de Zarate, Donostia-San Sebastian, Spain

   Alonso, M.(1); Marimon Ortiz de Zarate, J.M.(2)*; De la Caba, I.(1); Ercibengoa, M.(1); Pérez-Trallero, E.(3);

   13 May 2014

   Session: Improving treatment of severe infections

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   Oral presentation

   Bacterial Infection & Disease

6. O255

   Tailoring the empirical antimicrobial therapy in VAP patients by means of an E-test based direct testing

   Alexandre Boyer, Bordeaux, France

   M'Zali, F.(1)*; Goret, J.(2); Chalus, E.(2); Anquetil, D.(2); Bouchiat, C.(2); Clouzeau, B.(3); Bui, H.N.(3); Kann, M.(1); Gruson, D.(3); Boyer, A.(3);

   13 May 2014

   Session: Improving treatment of severe infections

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   Oral presentation

   Healthcare-associated & Nosocomial Infections, Infection Control

7. O256

   Cost-effectiveness of fidaxomicin as first-line treatment for Clostridium difficile infection

   John Nesnas, Tooting, United Kingdom

   Nesnas, J.(1); Whitney, L.(1); Ahmad, A.(2); Planche, T.(3)*

   13 May 2014

   Session: Improving treatment of severe infections

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   Oral presentation

   New Antibacterial Agents & Stewardship

8. O257

   Appropriate empiric antibiotic treatment does not reduce 30-day mortality among inpatients with catheter-associated urosepsis: observational cohort study

   Tanya Babich, Petah Tikva, Israel

   Babich, T.(1)*; Avni, T.(1); Paul, M.(2); Leibovici, L.(1);

   13 May 2014

   Session: Improving treatment of severe infections

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   Oral presentation

   New Antibacterial Agents & Stewardship

9. O258

   Antibiotic treatment of vertebral osteomyelitis

   Aurélien Dinh, Paris, France

   Dinh, A.(1)*; Ghout, I.(2); Mulleman, D.(3); Marchou, B.(4); Issartel, B.(5); Zeller, V.(6); Belmatoug, N.(7); Dupon, M.(8); Bernard, L.(9);

   13 May 2014

   Session: Improving treatment of severe infections

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   Oral presentation

   Bacterial Infection & Disease

10. O259

    Long-term benefit from clarithromycin treatment in patients with sepsis and ventilator-associated pneumonia (VAP): impact on the hospitalisation cost

    Thomas Tsaganos, Haidari, Greece

    Tsaganos, T.(1)*; Raftogiannis, M.(1); Pratikaki, M.(2); Christodoulou, S.(1); Kotanidou, A.(2); Papadomichelakis, E.(3); Routsi, C.(2); Giamarellos-Bourboulis, E.J.(1);

    13 May 2014

    Session: Improving treatment of severe infections

    Relevance:

     

    100%

     

    

    Event: ECCMID 2014
    Barcelona, Spain
    Oral presentation

    Healthcare-associated & Nosocomial Infections, Infection Control